Tuberculosis: all 1,435 studies
Page 14 of 15. Open to participants first (208), then studies with results posted, then the rest; newest registration first within each.
- Latent Tuberculosis Infection in Cancer PatientsCompletedNCT00507754
- Pulmonary Tuberculosis and Vitamin DStatus unknownNCT00507000Phase 3
- Early Antiretroviral Treatment and/or Early Isoniazid Prophylaxis Against Tuberculosis in HIV-infected Adults (ANRS 12136 TEMPRANO)CompletedNCT00495651Phase 3
- MDR TB, Levofloxacin, Multi-Drug-Resistant Pulmonary TuberculosisCompletedNCT00495339Phase 4
- Comparison of Nevirapine and Efavirenz for the Treatment of HIV-TB Co-infected Patients (ANRS 12146 CARINEMO)CompletedNCT00495326Phase 2/3
- Quantiferon-TB Gold in the Assessment of Latent TB in Patients Candidate to Treatment or Treated With TNFα AntagonistsStatus unknownNCT00491933Not applicable
- Efavirenz-based Versus Nevirapine-based Antiretroviral Therapy Among HIV-infected Patients Receiving RifampinCompletedNCT00483054Phase 3
- Efficacy Safety Study Comparing 2 Doses of NVP After Initiating Rifampin-containing TB TherapyCompletedNCT00476853Phase 2
- Pharmacokinetics of Emtricitabine/Tenofovir/Efavirenz in HIV-infected Patients With TuberculosisStatus unknownNCT00474435Phase 2
- Innovative Approaches to Tuberculosis ControlCompletedNCT00472316
- A Study of 2 Doses of a New TB Vaccine, MVA85A, in Healthy Volunteers Previously Vaccinated With BCGCompletedNCT00465465Phase 1
- Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected PersonsCompletedNCT00463086Not applicable
- Pharmacokinetic Issues of Moxifloxacin Plus RifapentineTerminatedNCT00460759Phase 1
- Safety and Immunogenicity of MVA85A, in Healthy Volunteers in Cape TownCompletedNCT00460590Phase 1
- Diagnosis of Active and Latent TB Infection With IFN-y Assays in African ChildrenStatus unknownNCT00456469
- Safety and Immunogenicity of MVA85A in Volunteers Latently Infected With TB.CompletedNCT00456183Phase 1
- Screening for Latent Tuberculosis in Healthcare Workers With Quantiferon-Gold Assay: A Cost-Effectiveness AnalysisStatus unknownNCT00449345
- A Phase I Trial of a LTK63 Adjuvated Tuberculosis Nasal Subunit Vaccine (Ag85B-ESAT6)TerminatedNCT00440544Phase 1
- Immediate Versus Deferred Antiretroviral Therapy for HIV-Associated Tuberculous MeningitisStatus unknownNCT00433719Not applicable
- A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Previously Received BCGCompletedNCT00427830Phase 1
- A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers Who Have Received BCG Immunisation 1 Month PreviouslyCompletedNCT00427453Phase 1
- A Phase I Study of the Safety and Immunogenicity of MVA85A in Healthy Gambian VolunteersCompletedNCT00423839Phase 1
- A Phase I Study of the Safety and Immunogenicity of a Recombinant MVA Vaccine Encoding a Secreted Antigen From M. Tuberculosis, Antigen 85A, Delivered Intradermally by a Needle Injection in Healthy Volunteers.CompletedNCT00423566Phase 1
- Rapid Characterization of Paucibacillary TB Along Tex/Mex BorderCompletedNCT00421798
- Trial of Adjunctive Vitamin D in Tuberculosis TreatmentCompletedNCT00419068Phase 3
- A Cluster-Randomized Trial of DOTS vs DOTS Plus Active Case FindingCompletedNCT00414882
- A RCT of Prednisone as Adjunctive Therapy for Hospitalized Patients With Pulmonary TB and HIV Co-infectionWithdrawnNCT00414414Phase 3
- Investigation of a Novel Approach to Improve Treatment Success Rates for Tuberculosis Patients in SenegalCompletedNCT00412009Phase 4
- The Pharmacokinetics and Safety of IDV/r With NRTIs in HIV/TB Co-infected Patients Receiving RifampicinCompletedNCT00411996Phase 1/2
- Study of Safety and Efficacy of Different Regimes of Reintroduction of Anti-TB Drugs in Anti-TB Drugs Induced Liver DamageCompletedNCT00405301Phase 4
- A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With AnergyCompletedNCT00402610Phase 4
- Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium TuberculosisCompletedNCT00402454Phase 4
- Comparison of Quantiferon-TB Gold Assay With Tuberculin Skin Testing in Patients With Chronic Liver DiseaseCompletedNCT00402402Phase 4
- Safety, Efficacy and Pharmacokinetics of OPC-67683 in Patients With Pulmonary TuberculosisCompletedNCT00401271Phase 2
- A Study to Compare Three Existing Starting Points of Anti-Retroviral Therapy (ART) Initiation in HIV/Tuberculosis (TB) Co-infected PatientsCompletedNCT00398996Phase 3
- Short-Course Isoniazid and Rifampin Compared With Isoniazid for Latent Tuberculosis InfectionTerminatedNCT00397709Phase 4
- BCG Vaccination Delivered Intradermally, Orally and by Combined RoutesCompletedNCT00396370Phase 1
- The Safety and Immunogenicity of a TB Vaccine; MVA85A, in Healthy Volunteers Who Are Infected With HIVCompletedNCT00395720Phase 1
- Short Course Intermittent Regimens for the Treatment of HIV-Associated TuberculosisStatus unknownNCT00376012Phase 3
- Pimonidazole Hydrochloride to Detect Low Oxygen in Tuberculosis-Infected LungsWithdrawnNCT00374517Phase 2
- A Clinical Trial to Study the Effect of the Addition of Vitamin D to Conventional Treatment in New Pulmonary Tuberculosis PatientsCompletedNCT00366470Phase 3
- Preventive Therapy for Tuberculosis in HIV Infected PersonsCompletedNCT00351702Phase 3
- Multi-Drug Resistant Tuberculosis in KoreaCompletedNCT00341601
- Efficacy and Safety of Immunomodulator as an Adjunct Therapy in New Pulmonary Tuberculosis(Category I) Patients.CompletedNCT00341328Phase 3
- Collection of Tissue Specimens in Mali, West Africa, for HIV and Tuberculosis ResearchTerminatedNCT00341042
- Immune Responses to Mycobacterium TuberculosisCompletedNCT00340990
- Corticosteroids in the Treatment of Tuberculous PleurisyCompletedNCT00338793Not applicable
- Safety and Efficacy of Two Once Daily Anti Retroviral Treatment Regimens Along With Anti-tuberculosis TreatmentStatus unknownNCT00332306Phase 3
- Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected ChildrenCompletedNCT00330304Phase 3
- A Randomized Trial of DOTS Versus Enhanced DOTS for Community Control of TuberculosisCompletedNCT00317330Phase 3
- Comparison the Level of CTGF Protein and Related Cytokine in Pleural EffusionStatus unknownNCT00313066
- Nutrition, Diabetes and Pulmonary TB/HIVCompletedNCT00311298Phase 3
- Use TST and QFT-RD1 Test to Monitor the Tuberculous Infection in Patients, Close Contact People and Health Care WorkersStatus unknownNCT00311220Phase 4
- Development of Tuberculosis Diagnostic KitStatus unknownNCT00311207
- Local Anesthesia and Tuberculin Skin Test in Infants and ChildrenStatus unknownNCT00309673Not applicable
- Pharmacokinetic Interaction Study in Indonesian Tuberculosis Patients IndonesiaCompletedNCT00306319Phase 2
- Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)CompletedNCT00298870Phase 4
- Treatment of Latent Tuberculosis Infection With IsoniazidCompletedNCT00293228Phase 4
- Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.CompletedNCT00291889Phase 1
- Identification of Cytokine Profiles and T Cell Subsets Among Immunosuppressed Patients at Risk of Developing Active TuberculosisStatus unknownNCT00285441
- The Molecular Mechanism and the Role of NRAMP 1gene on Tuberculosis in Taiwan Aboriginal Tribes PopulationCompletedNCT00266383
- Efficacy and Safety Study of Immunomodulator as an Adjunct Therapy in Pulmonary Tuberculosis (TB) Retreatment PatientsCompletedNCT00265226Phase 3
- Immune Response to Mycobacterium Tuberculosis InfectionCompletedNCT00257907
- Randomized Controlled Trial of Percutaneous and Intradermal BCG Vaccination.Status unknownNCT00242047Phase 4
- Effectiveness of Public Health Model of Latent Tuberculosis Infection Control for High-Risk AdolescentsCompletedNCT00233168Not applicable
- Early vs Late Introduction of Antiretroviral Therapy in HIV-infected Patients With Tuberculosis (ANRS 1295 CAMELIA)CompletedNCT00226434Phase 3
- A Controlled Trial of a 4-Month Quinolone-Containing Regimen for the Treatment of Pulmonary TuberculosisStatus unknownNCT00216385Phase 3
- Multicenter Trial for the Evaluation of a Fixed Dose Combined Tablet for the Treatment of Pulmonary TuberculosisStatus unknownNCT00216333Phase 4
- Can Screening People Registering With Primary Care Improve the Detection of Tuberculosis?WithdrawnNCT00214708
- Tuberculosis Research Blood BankWithdrawnNCT00212498
- Effect of Public Sector Antiretroviral Treatment Programme on Tuberculosis and Immunization CareStatus unknownNCT00203762Not applicable
- Expression of Tuberculosis in the LungCompletedNCT00201253
- Nutrition, Immunology and Epidemiology of TuberculosisCompletedNCT00197704Phase 3
- Food Incentives for TB Treatment Compliance in East Timor (FITTCET)CompletedNCT00192556Not applicable
- Diagnosis of Active Tuberculosis by ELISPOTStatus unknownNCT00174083
- Exogenous Reinfection of Tuberculosis in TaiwanCompletedNCT00173433
- Immunologic and Genetic Characteristics of Monoclonal Immunoglobulins in Patient With TuberculosisStatus unknownNCT00173264
- PPD Size and Mycobacteria Tuberculosis ELISPOT in Children Who Have Received BCG in Neonate PeriodStatus unknownNCT00172783
- Tuberculosis Immunity in ChildrenCompletedNCT00170638
- TB Nutrition, Immunology and EpidemiologyCompletedNCT00170404Phase 3
- Rifampin Versus Isoniazid for the Treatment of Latent Tuberculosis Infection in Children (P4v9)CompletedNCT00170209Phase 3
- TBTC Study 27/28 PK: Moxifloxacin Pharmacokinetics During TB TreatmentCompletedNCT00164463Phase 2
- Effects of Vitamin D Supplementation on Antimycobacterial ImmunityCompletedNCT00157066Not applicable
- Effectiveness of the TB Contact Priority ModelCompletedNCT00149448
- Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive AdultsCompletedNCT00146744Phase 2
- Should Low Birth Weight Infants Be Vaccinated With BCG Vaccine at Birth in Developing Countries?CompletedNCT00146302Phase 4
- Effect of Multivitamin Supplements on Clinical and Immunological Response in Childhood TuberculosisTerminatedNCT00145184Phase 3
- TBTC Study 28: Moxifloxacin Versus Isoniazid for TB TreatmentCompletedNCT00144417Phase 2
- TBTC Study 27: Moxifloxacin vs Ethambutol for TB TreatmentCompletedNCT00140309Phase 2
- Tuberculosis (TB) Screening for the Diagnosis of Latent TB in Immunocompromised PopulationsCompletedNCT00134342
- A Trial of Isoniazid for the Reversion of Interferon Gamma ELISPOT in Tuberculosis (TB) Case ContactsCompletedNCT00130325Not applicable
- Early Versus Standard Start of Anti-HIV Therapy for Treatment-Naive Adults in HaitiCompletedNCT00120510Not applicable
- Efficacy of Tenofovir-Emtricitabine and Efavirenz in HIV Infected Patients With Tuberculosis (ANRS129)CompletedNCT00115609Phase 3
- TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)CompletedNCT00107887Phase 4
- Safety, Tolerability, and Blood Levels of Ritonavir-Boosted Atazanavir and Rifampin When Taken Together in HIV Uninfected AdultsCompletedNCT00096850Not applicable
- Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited SettingsCompletedNCT00091936Not applicable
- Anti-HIV Drugs for Ugandan Patients With HIV and TuberculosisCompletedNCT00078247Phase 3
- Vitamin A Therapy for TuberculosisCompletedNCT00057434Phase 3
- Tuberculosis in HIV Infected Patients in UgandaCompletedNCT00057421Phase 2
- Tuberculosis Prevention for HIV Infected AdultsCompletedNCT00057122Phase 3